Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Vitalhub Corp T.VHI

Alternate Symbol(s):  VHIBF

Vitalhub Corp. provides technology to health and human service providers, including hospitals, regional health authorities, mental health, long-term care, home health, community and social services. The Company's solutions span the categories of electronic health records (EHR), case management, care coordination and optimization, and patient flow and operational visibility and solutionsIts... see more

TSX:VHI - Post Discussion

Vitalhub Corp > GREAT NEWS!!!!!!!!!!!!!!!!!
View:
Post by Bentley2000 on Aug 10, 2023 8:57pm

GREAT NEWS!!!!!!!!!!!!!!!!!

   
VitalHub Corp. Reports Second Quarter 2023 Results
2023-08-10 08:46:36 PM ET (GlobeNewswire)
   
 
   
TORONTO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- VitalHub Corp. (the "Company" or "VitalHub") (TSX:VHI) (OTCQX:VHIBF) announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and Analysis report for the three and six months ended June 30, 2023, with the Canadian securities authorities. These documents may be viewed under the Company's profile at www.sedar.com.



"We kicked off 2023 with record revenue and robust year-over-year growth. This momentum persisted in Q2 with continued new sales and client expansion" said Dan Matlow, Chief Executive Officer of VitalHub. "Both positive organic growth an d accretive revenue from acquisitions completed in previous quarters contributed to the Q2 2023 revenue increase. Strong double-digit year-over-year growth was delivered in term licences, maintenance, and support; perpetual licenses, services and hardware. ARR (1,2) benefited from positive organic growth (4%) offset by a loss (-0.3%) due to the decrease in Australian and US dollar rates relative to the Canadian dollar in the quarter. ARR (1,2) increased 31.4% or $9.8 million to $41.0 million from Q2 2022. Adjusted EBITDA (2) was strong at approximately $3.0 million, representing 23% of revenue. We closed the quarter with $22.9 million in cash on hand, a sequential increase of $5.8 million from December 31, 2022. Combined with the availability of our Bank of Nova Scotia Facility, we currently have $55.9 million of liquidity to expand our operations and continue our acquisition strategy. We continue to see new customer interest in our growing product p ortfolio in a more diversified fashion than in the past. In particular, our TREAT solution in the Canadian marketplace continues to expand on its leadership position. We are penetrating deeper into core accounts and expanding horizontally into adjacent markets and look forward to continuing our business velocity throughout 2023."
VitalHub Corp's quarterly investor conference call will take place on Friday, August 11, 2023, at 9:00AM EST.
To register for the call, please visit:
https://us02web.zoom.us/webinar/register/WN_inRMLjeLSSu7j3RHmPOprQ
Second Quarter 2023 Highlights
  • Revenue of $13,085,441, an increase of $3,607,977 or 38% from Q2 2022.
  • Gross profit as a percentage of revenue of 81% compared to 83% in Q2 2022 (Q1 2023 - 80%). The decrease in Q2 2023 was primarily due to an increase in lower margin service revenues in the quarter.
  • ARR (1, 2) at the end of Q2 2023 was $41,008,702, an increase of $1,374,185 from Q1 2023.
    • ARR (1, 2) growth consists of $1,491,003 or 4% organic growth, offset by a loss of $116,818 or 0.3% of foreign exchange changes due to the decrease in Australian and US dollar rates relative to the Canadian dollar in the quarter.
  • EBITDA (2) of $1,979,464 compared to $1,023,686 in Q2 2022.
  • Adjusted EBITDA (2) of $2,970,322, or 23% of revenue, compared to $1,866,563, or 20% of revenue, in Q2 2022.
    • The increase was primarily attributable to the higher recurring revenues of $10,210,367 in Q2 2023, as compared to $7,232,646 in Q2 2022.
       

  • Net income before income taxes of $742,516 for Q2 2023 compared to a net loss of $9,957 in Q2 2022.


    • The increase was primarily attributable to the significant increase in revenues from organic growth and acquisitions, and lower expenses as a percentage % of sales.
Six Month 2023 Highlights
  • ARR (1, 2) at June 30, 2023, was $41,008,702 as compared to $31,219,508 at June 30, 2022, an increase of 31%.

    • ARR (1, 2) growth consists of $4,748,634 or 15% organic growth, $4,100,854 or 13% of acquisition growth, and a gain of $939,705 or 3.0% due to the fluctuation in the British Pound relative to the Canadian dollar.
  • Gross profit as a percentage of revenue for the six months ended June 30, 2023 was 81% compared to 84% from the comparative period in the prior year.


     

  • Revenue of $25,680,615, an increase of $6,779,959 or 36% from the comparative period in the prior year.


     

  • EBITDA (2) of $3,967,211 compared to $3,390,734 in H1 2022.


     

  • Adjusted EBITDA (2) of $5,894,102, or 23% of revenue, compared to $ 4,917,582 or 26% of revenue in H1 2022.


     

  • Cashflow from operations before c hanges in working capital was $4,068,458 for the period as compared to $3,994,704 for the same period last year.


     

  • Cash on hand at June 30, 2023, was $22,944,268 compared to $17,452,210 as at December 31, 2022.

(1) The Company defines annual recurring revenue ("ARR") as the recurring revenue expected based on yearly subscriptions.

 
(2) Non-IFRS measure.




SELECTED FINANCIAL INFORMATION            
                     
  Three months ended Six months ended
  June 30, 2023 % Revenue June 30, 2022 % Revenue Change June 30, 2023 % Revenue June 30, 2022 % Revenue Change
  $   $   % $   $   %
Revenue 13,085,441   100 % 9,477,464   100 % 38 % 25,680,615   100 % 18,900,656   100 % 36 %
                     
Cost of sales 2,468,871   19 % 1,605,282   17 % (54 %) 4,940,748   19 % 3,079,861   16 % (60 %)
                     
Gross profit 10,616,570   81 % 7,872,182   83 % 35 % 20,739,867   81 % 15,820,795   84 % 31 %
                     
Operating expenses                    
General and administrative 2,558,469   20 % 2,160,235   23 % (18 %) 6,169,561   24 % 4,005,747   21 % (54 %)
Sales and marketing 1,739,979   13 % 1,023,250   11 % (70 %) 3,021,644   12 % 2,071,639   11 % (46 %)
Research and development 3,293,624   25 %< /td> 2,634,222   28 % (25 %) 5,813,645   23 % 4,658,589   25 % (25 %)
Depreciation of property and equipment 82,885   1 % 60,556   1 % (37 %) 158,168   1 % 103,873   1 % (52 %)
Depreciation of right-of-use assets 101,742   1 % 52,094   1 % (95 %) 197,649   1 % 115,482   1 % (71 %)
Stock based compensation 293,957   2 % 314,540   3 % 7 % 571,641   2 % 583,784   3 % 2 %
Deferred share-based compensation 97,560   1 % -   0 % 100 % 97,560   0 % -   0 % 100 %
Foreign currency loss (gain) 54,176   0 % 186,855   2 % 71 % (159,085 ) (1 %) 166,180   1 % 196 %
                       
Other income and expenses                    
Amortizat ion of intangible assets 1,070,214   8 % 795,270   8 % (35 %) 2,124,461   8 % 1,479,198   8 % (44 %)
Business acquisition, restructuring and integration costs 353,016   3 % 528,337   6 % 33 % 1,011,365   4 % 943,064   5 % (7 %)
Loss (gain) on change in fair value of contingent consideration 246,325   2 % 0   0 % 100 % 695,402   3 % (128,270 ) (1 %) 642 %
Interest expense and accretion (net of interest income) (37,368 ) (0 %) 110,405   1 % 134 % (76,355 ) (0 %) 105,686   1 % 172 %
Interest expense from lease liabilities 19,475   0 % 15,318   0 % (27 %) 40,344   0 % 32,936   0 % (22 %)
                     
Current and deferred income taxes 121,065   1 % (84,536 ) (1 %) 243 % 739,325   3 % 41,366   0 % (1687 %)
                     
Net income 621,451   5 % 74,579   1 % 733 % 783,619   3 % 1,512,194   8 % (48 %)
                     
EBITDA (Non-IFRS measure) 1,979,464   15 % 1,023,686   11 % 93 % 3,967,211   15 % 3,390,734   18 % 17 %
                     
Adjusted EBITDA (Non-IFRS measure) 2,970,322   23 % 1,866,563   20 % 59 % 5,894,102   23 % 4,917,582   26 % 20 %
                     
Annual recurring revenue (Non-IFRS measure) 41,008,702     31,219,508     31 % 41,008,702     31,219,508     31 %
                     
Term licences, maintenance a nd support revenue 10,210,645   78 % 7,232,646   76 % 41 % 20,208,129   79 % 12,965,537   69 % 56 %
                       
                       
                     
                  As at  
                  June 30, 2023 December 31, 2022
                  $ $
Deferred revenue                 24,668,947 15,495,461
                     
Cash balance                 22,944,268 17,452,210


ABOUT VITALHUB



Software for Health and Human Services providers designed to simplify the user experience and optimize outcomes.
VitalHub provides technology to Health and Human Services providers including Hospitals, Regional Health Authorities, Mental Health, Long Term Care, Home Health, Community and Social Services. VitalHub solutions span the categories of Electronic Health Record (EHR), Case Management, Care Coordination & Optimization, and Patient Flow & Operational Visibility solutions.
The Company has a robust two-pronged growth strategy, targeting organic growth opportunities within its product suite, and pursuing an aggressive M&A plan. Currently VitalHub serves more than 1,000 clients across Canada, USA, UK, Australia, the Middle East, and Europe.
VitalHub is based in Toronto, Canada, with an offshore development hub in Sri Lanka. The VitalHub team comprises more than 350 team members globally. The Company is publicly traded on the Toronto Stock Exchange (TSX) under the symbol "VHI" and on the OTC Markets OTCQX Exchange under the symbol "VHIBF".
https://www.vitalhub.com/
CAUTIONARY STATEMENT
Certain statements contained in this news release may constitute "forward-looking information" or "financial outlook" within the meaning of applicable securities laws that involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future re sults, performance or achievements expressed or implied by such forward-looking information or financial outlook. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "is expected", "expects", "scheduled", "intends", "contemplates", "anticipates", "believes", "proposes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Such statements are based on the current expectations of the management of each entity and are based on assumptions and subject to risks and uncertainties. Although the management of each entity believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
CONTACT INFORMATION
Dan Matlow

Chief Executive Officer, Director

(416) 727-9061

dan.matlow@Vitalhub.com




Primary Logo
comtex tracking
COMTEX_438198304/2010/2023-08-10T20:46:36
   
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities